Medtronic has developed a new GenCut core biopsy system that works with the firm's super dimension lung navigation system.
The device lets physicians take multiple core biopsy samples within hard to reach areas of the lungs. Medtronic promises that a new blade design, GenCut can harvest larger intact samples than was previously possible.
Pathologists would be able to easily arrive at diagnoses and because only one pass is necessary, patients will benefit from fewer separate biopsies.
"Lung cancer diagnostic clinicians consistently state that tissue is the issue. When performing a biopsy, they need enough tissue for the pathologist to make a diagnosis and to ensure undamaged tissue for genetic testing and molecular analysis. As lung cancer drugs and therapies advance, the ability to provide earlier diagnosis and earlier, personalized treatment can potentially save lives," said Chuck Brynelsen, president, Early Technologies business in Medtronic's Minimally Invasive Therapies Group.
The device also helps to gather healthy tissue that can be used for genetic and molecular testing, comparing it to the tissue gathered from suspect lesions, all in one run.